Outcome of Board Meeting

Rainbow® Children's ~ BirthRighf Hospital ~ - BY RAINBOW HOSPITALS WOMEN CARE I CHILD CARE I FERTILITY October 31, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot No. C/1, G Block, Corporate Relationship Department, Bandra Kurla Complex, Bandra (E), Phiroze Jeejeebhoy Towers, Mumbai - 400051. Dalal Street, Mumbai - 400001. Symbol: RAINBOW Scrip Code: 543524 Sub: Outcome of the Board Meeting held on October 31, 2026. Dear Sir/ Madam, This is to inform that pursuant to Regulations 30 and 33 read with Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the SEBI Listing Regulations”) and in furtherance of our letter dated October 23, 2026, the Board of Directors of the Company, at its meeting held today i.e., October 31, 2026, has considered and approved the following: 1. Financial Results: The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026 ("Financial Results"). A copy of the signed Results along with Limited Review Report issued by the Statutory Auditors M/s. S.R. Batliboi & Associates LLP, Chartered Accountants, are enclosed as Annexure – A. The Board Meeting commenced at 4:45 P.M and concluded at 5:15 P.M. This is for your information and record. Thanking You, Yours Faithfully, For Rainbow Children’s Medicare Limited Shreya Mitra Company Secretary and Compliance Officer Encl.: As above Rainbow Children's Medicare Limited Registered Office: 8-2-120/103/1, Survey No. 403, Road No. 2, Banjara Hills, Hyderabad- 500034, Telangana CIN :L85110TG 1998PLC029914 Q Corporate Office: 8-2-19/1/A, Daulet Arcade, Road No. 11, Banjara Hills, Hyderabad- 500034, Telangana G info@rainbowhospitals.in \;' 1800 2122 iffil www. rainbowhospitals.in OUR PRESENCE: BENGALURU CHENNAI DELHI GUWAHATI HYDERABAD RAJAHMUNDRY VIJAYAWADA VISAKHAPATNAM WARANGAL S.R. BATLIBOI & ASSOCIATES LLP THE SKYVIEW 20 2nd Floor, Unit No: 201 & 202 Left Wing, Survey No. 83/1 Chartered Accountants Hyderabad -500 032 India Tel: +9140 6141 6000 Independent Auditor's Review Report on the Quarterly and Year to Date Unaudited Standalone Financial Results of the Rainbow Children's Medicare Limited Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended Review Report to The Board of Directors Rainbow Children's Medicare Limited I. We have reviewed the accompanying statement of unaudited standalone financial results of Rainbow Children's Medicare Limited (the "Company") for the quarter ended 30 September 2026 and year to date from 1 April 2026 to 30 September 2026 (the "Statement") attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 20 I 5, as amended (the "Listing Regulations"). 2. The Company's Management is responsible for the preparation of the Statement in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, (Ind AS 34) "Interim Financial Reporting" prescribed under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The Statement has been approved by the Company's Board of Directors. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chat1ered Accountants of India. This standard requires that we plan and perfonn the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standards (' Ind AS') specified under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. ForS.R. BATLIBOI & ASSOCIATES LLP Chat1ered Accountants ICAI Firm registration number: IOI 049W/E300004 per Atin Bhargav Partner Membership No.: Place: Hyderabad Date: October 3 I, 2026 S.R. Batliboi & Associ<1tes LLP, a Limited Liability Partnership with LLP Identity No. AAB-4295 Regd. Office: 22, Camac Street. Block ·a·. 3rd Floor, Kolkata·700 016 Rainhon Childrrn's l\1edicarr UmitC'd CIN: L851I OTG19981'LC029914 Hcgistcrcd Office: 8-2-120/103/1, Survey No. 403. Road No.2, Banjara Hills, Hyderabad. Telangana-500034 Tel: +91404969 22H. e-mail: companysecretary@:rainbo\\hospitals.in ---· St~~~ent of t:nauclifcd SIa~~~~1~e Finanrh1I Rcsulls for thr qunrler nnd )"Car to dale rnd(•d 30 September 2026 - (Rs. in Million "ccpt 1,er share dl!h1) Particulars Quarter ended Yenr to datr ended Year ended 30 Scplcmber 2026 30 June 2026 30 September 2025 30 September 2026 30 September 2025 31 March 2026 Unaudited UnaU<litcd Unaudited Um1uditccl Unaudited Audited I. Income a. Revenue from operations 4.869.91 4.105.47 4.084.96 8,975.38 7.432.44 15.456.60 b. Other income 80.92 127.57 81.73 208.49 274.58 434.54 Totnl income 4,950.83 4.233.04 4,166.69 9.183.87 7,707.02 15,891.14 2. Expenses a. Cost of mmerinI s COilsumcd 641.10 546.85 560.93 I.I 87.95 1.00043 1,996.69 b. Employee benefits expense 672.36 599.08 532.74 1,271.44 1.025.10 2.123.93 c. f"inance costs 199.14 I 92.49 173.09 391.63 347.02 713.96 d. Depreciation and amortis:ition expense 398.09 376.26 331.82 774.35 657. 75 1,362.61 e. Professional fees to doctors 1,242.43 J. 087.30 966.26 2.329. 73 1.834.07 3.770.65 f. Other expenses 799.06 725.65 617.85 1.524.71 1.170.45 2.566.76 Total cxpcns<"s 3,952.18 3,527.63 3.182.69 7.479.81 6,034.82 12,534.60 J. Profit before• excc,ptiomtl itc.•ms and tu:-.: 11-21 998.65 705.41 984.00 1,704.06 1,672.20 3.356.54 4. Exceptional itrms - 15.39 5. Profit before tax 13-41 998.65 705.41 984.00 1,704.06 1,672.20 3,341.15 6. Tax expenses a. Curre11l tax 305. 19 I 89.59 280.20 494.78 44 .85 917.83 b. DcfcJTcd tax credit (57.47) (11.24) (27.87) (68.71) (22.06) (73.38) c. Adjustment ofta.x relating to earlier periods (3.46) (3.46) Total tax expense 247.72 178.35 252.33 426.07 423.33 840.99 7. Profit after tax IS-61 750.93 527.06 731.67 l ,277.99 1,248.87 2,500. I 6 8. Ot11l'r comprehensive income Items thal will not be reclassified subsequently to 1hc Statement of Profit or I. oss :=i. lfr-mrasu1{~mcnt loss on defined bcnefil obligalion (2.21) (2.21) (0.72) (4.42) (1.44) (S.83) b. Income tax effect 0.55 0.56 0.18 I.II 0.36 2.22 Other c-ompre-htnsiYC, income-(nN of lax) 11.661 11.65) /0.541 13.31) (1.08) <6.6n 9. Tof:il comprrhcnsi\"C income-17+8I 749.27 ,2s.41 731.13 1,274.68 1,247.79 2.493.55 10. Pnid-up N(Uit.1 share capilal (Face l'nluc of Rs. JO eflch) 1,015.66 1.015.66 1,015.59 1.015.66 1.015.59 1.015.59 11. Other equity 15.874.98 12. Earning JJcr share (Fncc value of Rs.JO <'ach) a. Basic (Rs) 7. [Showing first 8,000 characters — download PDF for full document]